PATENT CLAIM ANALYSIS

Application Number: 16041483
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "015100"]

Abstract:
The invention relates to the use of an isolated peptide of 10 to 32 amino acid residues in length for the treatment of neural injury, wherein the isolated peptide comprises at least 10 to 22 arginine residues. The peptide may be a poly-arg sequence or an arginine-rich peptide.

Claim (Index 37):
The method of  claim 35 , wherein said patient is administered an effective amount of said polypeptide including at least one poly-arginine segment comprising at least 4 contiguous arginine residues.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 95.0
- Lexical Diversity: 1.41667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12328625', '12514773', '15745432', '14782912', '13066700']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7521027438875582
- 35 USC 102 Novelty (BERT): 0.5078507263191687
- Combined Prediction Score: 0.7276775421307192
- Mean Citation Score: 249.166218
- Max Citation Score: 266.10522000000003
- Similarity Product: 181.3393397110892

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test